Resources from the same session
220O - RATIONALE-309: Effects of tislelizumab on health-related quality of life (HRQoL) in patients with recurrent or metastatic nasopharyngeal cancer (R/M NPC)
Presenter: Yunpeng Yang
Session: Proffered Paper session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
221O - Induction chemotherapy regimen of docetaxel plus cisplatin vs docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of a phase III multicenter randomized controlled trial
Presenter: SHASHA HE
Session: Proffered Paper session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
222O - Updated efficacy and safety of larotrectinib in patients with TRK fusion salivary gland tumours
Presenter: Lin Shen
Session: Proffered Paper session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
Invited Discussant 220O, 221O and 222O
Presenter: Ana Martins Ferreira Varges Gomes
Session: Proffered Paper session: Head and neck cancer
Resources:
Slides
Webcast
Q&A and discussion
Presenter: Sheng-Po Hao
Session: Proffered Paper session: Head and neck cancer
Resources:
Slides
Webcast
223O - Exosomal miRNA and mRNA signatures as biomarker for head and neck cancer
Presenter: Linda Hofmann
Session: Proffered Paper session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
224O - Survival differences between EU and Asia for head and neck cancer: Results of the RARECAREnet-Asia collaboration
Presenter: Annalisa Trama
Session: Proffered Paper session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Presenter: Sheng-Po Hao
Session: Proffered Paper session: Head and neck cancer
Resources:
Slides
Webcast